Powerful Medical
26. July 2023

PMcardio Exhibits at ESC Congress 2023 in Amsterdam

We are excited to announce that PMcardio will participate in the prestigious ESC Congress 2023 in Amsterdam, a leading global event in cardiology. This presents a remarkable opportunity to showcase our groundbreaking research advances to the heart-health community.

Join us at our PMcardio Booth (DH15) in the Digital Health Area. Experience firsthand the transformative power of our certified medical device, PMcardio, which breaks new ground in primary, emergency, and hospital care across 16 European countries. This event will provide a unique opportunity to meet our team and personally try out PMcardio, offering an immersive look into the future of AI-powered solutions in cardiology.

Our distinguished team members, Dr. Robert Herman and Dr. Anthony Demolder, along with Dr. Jelle Himmelreich, who conducted an independent study on PMcardio, will showcase their research in the dynamic landscape of AI-assisted cardiac diagnostics.

Powerful Medical Research at ESC Congress 2023:

  • “Validation of Artificial Intelligence Model for 12-lead ECG Interpretation” Dr. Anthony Demolder 26. August 2023, 08:15
  • “Diagnostic accuracy of a smartphone application for artificial intelligence-based interpretation of 12-lead ECG in primary care” Dr. Jelle Himmelreich 26. August 2023, 08:30
  • “ECG-based Deep Learning for Detecting Epicardial Occlusion in Acute Myocardial Infarction” Dr. Robert Herman 28. August 2023, 08:15
  • “Poor Prognosis of Total Culprit Artery Occlusion in Patients Presenting with NSTEMI” Dr. Robert Herman 28. August 2023, 16:15

About ESC Congress:

The ESC Congress 2023, organized by the European Society of Cardiology (ESC), is the world’s largest conference in cardiovascular medicine. It will be held from August 25 to August 28, 2023, in Amsterdam, Netherlands. The theme of the congress is “Joining forces to protect the heart”. The spotlight of ESC Congress 2023 will be heart failure, which is relevant to all areas of cardiology and beyond. The congress aims to provide the latest research findings, in-depth science, and clinical teaching in cardiovascular medicine.

PMcardio Exhibits at ESC Congress 2023 in Amsterdam
PMcardio Exhibits at ESC Congress 2023 in Amsterdam

Stay on the pulse with our newsletter

Your submission was successful

Powerful Medical

Powerful Medical leads one of the most important shifts in modern medicine by augmenting human-made clinical decisions with artificial intelligence. Our primary focus is on cardiovascular diseases, the world’s leading cause of death.
Powerful Medical leads one of the most important shifts in modern medicine by augmenting human-made clinical decisions with artificial intelligence. Our primary focus is on cardiovascular diseases, the world’s leading cause of death.
About PMcardio:

PMcardio is the market leader in AI-powered diagnostics, addressing the world’s leading cause of death – cardiovascular diseases. The innovative clinical assistant empowers healthcare professionals to detect up to 40 cardiovascular diseases. In the form of a smartphone application, the certified Class IIb medical device interprets any 12-lead ECG image in under 5 seconds to provide accurate diagnoses and individualized treatment recommendations tailored to each patient.

About Powerful Medical:

Established in 2017, Powerful Medical has embarked on a mission to revolutionize the diagnosis and treatment of cardiovascular diseases. We are a medical company backed by 28 world-class cardiologists and led by our expert Scientific Board with decades of experience in daily patient care, clinical research, and medical devices. The results of our research are implemented, developed, certified, and brought to market by our 50+ strong interdisciplinary team of physicians, data scientists, AI experts, software engineers, regulatory specialists, and commercial teams.

Share this article

Don't miss these

Dr. Schmelzer’s Turning Point: How a Severe Chest Pain Case Inspired PMcardio Adoption

The case of a 76-year-old patient with severe chest pain prompted Dr. Schmelzer to delve into the nuances of Occlusive Myocardial Infarction (OMI) versus the conventional STEMI/NSTEMI classification. His research led him to discover the PMcardio OMI AI model.
Left Ventricular Systolic Dysfunction (LVSD) (2)

Left Ventricular Systolic Dysfunction: The Basics and Advancements in Detection

In this comprehensive article, we delve into the intricacies of Left Ventricular Systolic Dysfunction (LVSD), thoroughly analyzing its symptoms, causes, and severity. We explore the latest advancements in diagnostic tools and real-world case studies.

Join 25,000 healthcare professionals who are already taking advantage of AI